Navigation Links
“Nap Nanny” Deaths Grounds for Lawsuit
Date:1/5/2013

(PRWEB) January 05, 2013

Five infants have now died in what has become an ongoing series of product recalls. Nap Nanny, a series of baby recliners designed to hold infants during naptime, has reportedly led to repeated injuries, product failures and child fatalities state CBS Local. A voluntary recall of the recliners has been been issues by the US Consumer Product Safety Commission (CPSC), but attorney Gary Iscoe says this won't be enough to address the problems the product has caused.

The recall is the second in two years. An earlier generation of Nap Nannies was recalled in 2010 by the manufacturer, Baby Matters LLC, after an infant died. Changes in the design, instructions and parental warnings allowed the company to continue selling Nap Nannies. Since then the CPSC has received 70 new reports of children nearly falling out of the recliners, and the reported death count has risen to five reported CBS.

“Recalling these products is long overdue,” said Iscoe, an injury attorney who frequently sees cases involving unsafe products. “But the recall doesn't help address the deaths and injuries that already occurred.”

Iscoe stressed that young children are particularly fragile. “Often, the full extent of an injury is not immediately apparent with a toddler or baby. If I saw my child hanging out of one of these baby seats I would want to talk to both a doctor and a lawyer.”

The families affected by the Nap Nannies are likely to sue Baby Matters, Iscoe believes. “I hope every family who filed a complaint steps forward. Talk to a lawyer and find out what your options are. When a company puts children in danger, they
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Overestimation of abortion deaths in Mexico hinders maternal mortality reduction efforts
2. Latest West Nile Tally: 5,245 Cases, 236 Deaths
3. Kentucky study finds common drug increases deaths in atrial fibrillation patients
4. Routine Checkups Dont Cut Cancer, Heart Deaths: Study
5. AIDS Deaths, New HIV Infections Continue to Drop Worldwide
6. Pneumonia remains the leading killer of children despite decline in global child deaths
7. CDC: West Nile Toll Now 5,054 Cases, 228 Deaths
8. Smoke-free laws lead to fewer hospitalizations and deaths
9. Winter Brings Rise in Heart-Related Deaths, Study Finds
10. COPD Deaths Highest in Rural, Poor Areas: CDC
11. Study shows anaesthetic-related deaths reduced dramatically
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2014)... Ever since it was first identified more than ... to play an integral role in preventing the onset ... either lost or mutated, malignant cells can grow unchecked ... by investigators at Beth Israel Deaconess Medical Center (BIDMC) ... effects and how its loss or alteration can set ...
(Date:4/24/2014)... TORONTO Baker,s yeast is giving scientists a better ... of hospitalization and illness world-wide. , When two ... one can suppress or enhance the effectiveness of the ... of another. These types of interactions are a major ... severe practical limits on the practical scope of drug ...
(Date:4/24/2014)... stressful outcomes for parents who have a child born ... a recent study led by a researcher at the ... and life-changing and stress levels high, the vast majority ... positive outcomes as well, a phenomenon known as posttraumatic ... of the American Journal of Orthopsychiatry . , ...
(Date:4/24/2014)... 24, 2014 ,Take me out to the ballgame, ... kale chips. The more likely culprits include French fries, ... Unfortunately for children who play youth baseball, eating unhealthy ... weight problems, according to researchers at Wake Forest Baptist ... edition of Childhood Obesity , found that high-calorie ...
(Date:4/24/2014)... the Center for BrainHealth will bring together national ... brain-related challenges at its inaugural Brain Health Summit, ... Featured speakers will include Dr. Sandra Bond Chapman, ... BrainHealth, U.S. Senator Chuck Grassley (R-IA), U.S. Representative ... Secretary for Policy and Early Learning, U.S. Department ...
Breaking Medicine News(10 mins):Health News:Surprising new insights into the PTEN tumor suppressor gene 2Health News:Surprising new insights into the PTEN tumor suppressor gene 3Health News:Large-scale identification and analysis of suppressive drug interactions 2Health News:Parents of severely ill children see benefits as caregivers, says study 2Health News:Take the bat, leave the candy 2Health News:Inaugural Brain Health Summit focuses on brain resilience and regeneration 2
... The discovery 15 years ago that the genes BRCA1 ... cancer was a breakthrough for cancer prediction and therapy, ... Prof. Alfons Meindl (Klinikum rechts der Isar of the ... Germany, the U.K., and the U.S., can identify another ...
... likely to be screened, study finds , WEDNESDAY, April 21 ... are being screened for skin cancer, a particular problem among ... common cancer screenings, a new study has found. , Researchers ... and older, who took part in the 2005 National Health ...
... ... , ... (Vocus) April 21, 2010 -- SafeShot Technologies, LLC , a leader in safety ... Emeritus Professor of Surgery at Keck School of Medicine, University of Southern California. Dr. ...
... Washington, DC -- For women with hormone receptor-positive breast ... daily dose of an anti-hormone drug will block the ... breast cancer at bay. The treatments work like ... resistant to therapy. With no other treatment options, ...
... clinical trials have shown that non-steroidal anti-inflammatory drugs ... colon cancer and precancerous polyps in humans. Now, ... that an investigational form of naproxen, called nitric ... earliest molecular changes that lead to colorectal cancer ...
... taken a major step forward in the understanding of ovarian ... Researchers have found that patients with hereditary ovarian cancer ... more likely to experience secondary tumours in their liver and ... is better than other patients. In non-hereditary cancer, ovarian ...
Cached Medicine News:Health News:Researchers identify a new breast and ovarian cancer susceptibility gene 2Health News:Few Over 50 Get Skin Cancer Screenings 2Health News:SafeShot Technologies Names Dr. Robert W. Beart as New Chief Executive Officer 2Health News:SafeShot Technologies Names Dr. Robert W. Beart as New Chief Executive Officer 3Health News:1 big problem with many possible solutions 2Health News:1 big problem with many possible solutions 3Health News:1 big problem with many possible solutions 4Health News:1 big problem with many possible solutions 5Health News:1 big problem with many possible solutions 6Health News:1 big problem with many possible solutions 7Health News:Researchers show that nitric oxide-donating naproxen can boost colorectal cancer prevention 2Health News:Ovarian cancer study offers vital clues for new therapies 2
(Date:1/15/2014)... Ky. , Jan. 15, 2014  Manufacturers, suppliers ... must be able to protect their most important ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of ... it steadfastly remains one of the most litigious ...
(Date:1/15/2014)... PHILADELPHIA , Jan. 15, 2014  Echo Therapeutics, Inc. ... company developing its Symphony® CGM System as a non-invasive, ... Robert F. Doman , Executive Chairman and Interim CEO ... Capital Markets, Tenth Annual Equity Conference. ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... India Drug Forecast and Market Analysis to ... PharmaPoint: Atopic Dermatitis - India Drug ...
Breaking Medicine Technology:Intellectual Property Insurance for Medical-related Products and Services 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 2Echo Therapeutics to Present at the Noble Financial Capital Markets' Tenth Annual Equity Conference 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5
... of, collaboration with investigators worldwide to develop new treatments for ... diverse forms of cancer ... on relapse rate of patients with early-stage breast cancer, - Four oral ... results of RECORD-1 study in renal cell ...
... Mich. and TOULOUSE, France, May 15 ... company,developing HDL-related compounds for the treatment of ... has completed a Phase I,clinical trial for ... candidates.,CER-002 is a peroxisome proliferator-activated receptor (PPAR),delta-specific ...
Cached Medicine Technology:Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Cerenis Therapeutics Completes Phase I Clinical Trial of CER-002 for Treatment of Cardiovascular Disease 2
Fine angled tips ideal for grasping delicate capsule. Angled 12 mm shafts with iris stop allows ease of movement in the anterior chamber. Flat handle with dull finish. Manufactured in titanium....
Gently curved shaft with 2 mm platform ideal for performing capsulorhexis through a tunnel incision. Flat handle with dull finish....
Fine angled 12 mm shafts and iris stop. Round handle for fingertip rotational control. Dull finish....
Gently curved jaws with fine angled sharp tips for puncture and grasping the capsule. Round handle is excellent for precise finger tip control. Made in titanium....
Medicine Products: